Position in NTRA
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$100,707
+$99,758 QoQ
Shares Held
371
+6083.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#681
of 844 holders
Holding Since
Mar 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026State of Wyoming holds $9,049,964 across 23 Diagnostics & Research names. NTRA ranks #17 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ICLR |
Icon PLC
|
22,228 | $3,861,225 | |
| 2 | SHC |
Sotera Health Co
|
56,651 | $1,005,555 | |
| 3 | MYGN |
Myriad Genetics Inc
|
107,783 | $615,440 | |
| 4 | GH |
Guardant Health, Inc.
|
2,620 | $393,078 | |
| 5 | VCYT |
Veracyte, Inc.
|
6,192 | $363,656 | |
| 6 | NEO |
Neogenomics Inc
|
19,811 | $289,042 | |
| 7 | GRAL |
GRAIL, Inc.
|
3,982 | $271,851 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
1,196 | $271,240 |
All Filings in NTRA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $100,707 | 371 | Shares | Sole | 2026-08-06 | |
| 2024-12-31 | $949 | 6 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,285 | 18 | Shares | Sole | 2024-11-14 | |
| 2022-06-30 | $1,523 | 43 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $21,926 | 539 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $57,808 | 619 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $55,720 | 500 | Shares | Sole | 2022-02-14 | |
| 2021-06-30 | $82,195 | 724 | Shares | Sole | 2022-02-14 | |
| 2021-03-31 | $54,425 | 536 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||